Brought to you by 
InfraReDx brings in $24.2mm through its Series E round
30 Jun 2011
Executive Summary
InfraReDx Inc. (cardiovascular diagnostic imaging systems) has raised $24.2mm through the closing of what is believed to be its Series E venture round. There were 42 undisclosed current shareholders that participated in the financing. The company will use the funds to increase its manufacturing operations and commercial infrastructure for the FDA-approved LipiScan intravascular ultrasound coronary imaging system. The money will also support clinical trials to evaluate additional applications of LipiScan.
Deal Industry
- Medical Devices
-
Medical Devices
- Laser
-
Surgical Equipment & Devices
- Minimally or Less Invasive
-
Diagnostic Imaging Equipment & Supplies
- Ultrasound
Deal Status
- Final
Deal Type
-
Financing
- Venture Financing
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
InfraReDx brings in $24.2mm through its Series E round
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice